DiaMedica Therapeutics Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D Expenses | 8.0M | 6.7M | 6.4M | 5.8M | 5.7M | 6.5M | 5.0M | 3.9M |
| Operating Expenses | 10.5M | 9.2M | 9.0M | 8.0M | 8.1M | 8.4M | 6.9M | 5.6M |
| Operating Income | -10.5M | -9.2M | -9.0M | -8.0M | -8.1M | -8.4M | -6.9M | -5.6M |
| Other Income / Gains | 447K | 483K | 419K | 314K | 443K | 528K | 616K | 526K |
| Net Income | -10.0M | -8.7M | -8.6M | -7.7M | -7.7M | -7.9M | -6.3M | -5.1M |
| EPS (Diluted) | -0.19 | -0.17 | -0.17 | -0.18 | -0.18 | -0.18 | -0.15 | -0.13 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 2.5M | 2.5M | 2.6M | 2.2M | 2.5M | 1.9M | 1.9M | 1.7M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 2.5M | 2.5M | 2.6M | 2.2M | 2.5M | 1.9M | 1.9M | 1.7M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 10.5M | 9.2M | 9.0M | 8.0M | 8.1M | 8.4M | 6.9M | 5.6M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 11K | 11K | 18K | 3K | 11K | 11K | 10K | 10K |
| Ebitda | -10.0M | -8.7M | -8.6M | -7.7M | -7.7M | -7.9M | -6.3M | -5.1M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -10.0M | -8.7M | -8.6M | -7.7M | -7.7M | -7.9M | -6.3M | -5.1M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | -7K | 10K | 6K | 6K | 6K | 9K | 7K | 7K |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.19 | -0.17 | -0.17 | -0.18 | -0.18 | -0.18 | -0.15 | -0.13 |
| Weighted Average Shs Out | 53.8M | 47.0M | 49.6M | 43.0M | 42.8M | 42.8M | 42.8M | 38.1M |
| Weighted Average Shs Out Dil | 53.8M | 47.0M | 49.6M | 43.0M | 42.8M | 42.8M | 42.8M | 38.1M |